Most PAH patients who completed one year in a CS1 expanded access program had stable or improved clinical measures.

Reflecting on this year's PHA conference in Dallas, columnist Mike Naple writes that connecting with community can be the ...

A study linked elevated blood levels of uric acid, a metabolic breakdown product often associated with gout, to a higher risk ...

Nine members of the pulmonary hypertension (PH) community have received awards for their support of the Pulmonary ...

Blocking a signaling pathway in certain white blood cells may prevent blood clots from obstructing blood flow in the pulmonary arteries — the cause of chronic thromboembolic pulmonary hypertension ...

At the Pulmonary Hypertension Association’s (PHA) biannual conference, it is easy to feel like you should be able to do more. There are sessions to attend, people to meet, dinners to join, and ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Corvista Health will collaborate with Mayo Clinic to evaluate ...

Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the pulmonary arteries. It is diagnosed when the arteries that transport blood from the heart ...

Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears to be working as intended, according to newly ...